About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5003501
Allelic
Composition
Psen1tm1Lpr/Psen1tm1Lpr
Tg(Thy1-APPSL)28Lpr/0
Genetic
Background
involves: 129 * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Psen1tm1Lpr mutation (0 available); any Psen1 mutation (48 available)
Tg(Thy1-APPSL)28Lpr mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• some plaques are detected at 2 months of age in the cervical spinal cord and plaques increase with age (J:128106)
• plaque formation is higher in the cervical spinal cord compared to the thoracic and lumbar regions (J:128106)
• plaques are almost exclusively found in the gray matter (J:128106)
• amyloid plaques are located frequently within the granular cell layer of the dentate gyrus (J:139736)
• significant plaque formation is detected in the frontal cortex by 2 months of age (J:146342)
• from 6 to 12 months of age plaques become more densely packed (J:146342)
• amyloid beta plaques form but no intracellular aggregates are seen
• numerous plaques form between 2 and 6 months of age and the pathology increases with age
• unlike in the frontal cortex, no neuronal loss is detected in the thalamus
• the granule cell layer is less densely packed at 12 months of age compared to 2 months of age
• the granule cell border is often frayed
• ectopic cells that are often orientated towards extracellular amyloid deposits can be detected at 2 months of age
• amyloid plaques are located frequently within the granular cell layer of the dentate gyrus
• decrease in the number of dentate gyrus granule cells at 12 months of age
• decrease in the number of dentate gyrus granule cells at 12 months of age
• massive intra- and extra-cellular amyloid beta deposits are detected in the frontal cortex at as early as 1.5 months of age, before significant plaque formation is detected
• by 6 months of age intracellular accumulations are no longer a prominent pathological feature
• a 28% and 35% loss of neurons is seen in the frontal cortex at 6 and 12 months of age, respectively, compared to age-matched controls
• frontal cortex volume is reduced compared to controls at 6 and 12 months of age
• thickened and irregularly shaped neurites are seen in the medulla at 14 months of age
• axonal spheroids are detected in pons and cortical areas at 6 months of age and in the spinal cord mostly along the anterior margin of the ventral horn and less frequently in the intermediolateral and dorsal horn
• at 10 and 14 months of age axonal spheroids are detected in pons, cortex, medulla, midbrain, hippocampus, corpus callosum and striatum
• larger axonal varicosities are seen in the medulla at 14 months of age
• large axonal dilatations are localized in white matter fiber tracts in close vicinity to the ventral horn in the spinal cord
• dilated axons often display thinned or focally absent myelin sheaths
• increased deposition of myelin ovoids in the white matter
• a 28% and 35% loss of neurons is seen in the frontal cortex at 6 and 12 months of age, respectively, compared to age-matched controls

homeostasis/metabolism
• some plaques are detected at 2 months of age in the cervical spinal cord and plaques increase with age (J:128106)
• plaque formation is higher in the cervical spinal cord compared to the thoracic and lumbar regions (J:128106)
• plaques are almost exclusively found in the gray matter (J:128106)
• amyloid plaques are located frequently within the granular cell layer of the dentate gyrus (J:139736)
• significant plaque formation is detected in the frontal cortex by 2 months of age (J:146342)
• from 6 to 12 months of age plaques become more densely packed (J:146342)
• significant decrease in plasma cholesterol between 2 and 6 months of age that is not seen in wild-type controls or either single transgenic mice
• basal cholesterol levels are increase compared to wild-type controls probably as a result of differences in strain background

behavior/neurological
• at 10 and 14 months of age
• impaired performance in a balance beam test at 10 and 14 months of age

growth/size/body
• at 10 and 14 months of age compared to mutant mice not carrying the transgene

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Alzheimer's disease DOID:10652 J:128106


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory